Strategic Growth LSO has expanded through acquisitions including J-Pac Medical and strategic manufacturing assets, signaling a growth trajectory and potential for cross-sell of sterilization, packaging, and validation services to new and existing clients.

Executive Leadership Recent appointment of a new CEO and prior CFO hires indicate leadership focus on scale, operations, and strategic partnerships, presenting opportunities to engage at the executive level for larger, multi-site contracts and integrated outsourcing programs.

Integrated Services MDM provides end-to-end sterile product preparation with traceability and device history records, offering a compelling value proposition for medical device companies seeking reliable supply chain documentation and compliant manufacturing through one partner.

Digital and Analytics Adoption of multiple marketing and operational platforms (NetSuite, Azure, Asana, Pardot) suggests a tech-enabled organization receptive to process improvements, reporting enhancements, and scalable partnering models that leverage data-driven quality and efficiency gains.

Mid-Mize Opportunity With revenue in the mid-market range and a headcount under 500, target mid-sized medical device firms seeking flexible outsourcing, sterilization validation, and packaging solutions to cost-effectively scale production and meet regulatory timelines.